Coronavirus / COVID

The CDC has confirmed an infection with the virus that causes COVID-19 in California in a person who reportedly did not have relevant travel history or exposure to another known patient with COVID-19

Among a cohort of 9 pregnant women who developed COVID-19 pneumonia, there was no evidence of vertical transmission to infants.

The randomized controlled trial will assess the activity of the antiviral remdesivir among hospitalized adults at the University of Nebraska Medical Center.

Studies have shown that human coronaviruses can survive for days on certain surfaces. What does this mean for infection prevention efforts?

A commentary agrees with World Health Organization recommendations against routine use of corticosteroids in treatment of COVID-19.

In a scenario where health care preparedness is key, what are the best strategies for US hospitals to pursue?

There could be viable options within a few months, but will it be in time to contain an outbreak?

The fact remains that this strain of coronavirus is not highly contagious; it behaves very similarly to other infectious viruses by targeting mainly the weak and/or immunocompromised portions of the population.

Screening for 2019 novel coronavirus continues around the world. A new research letter on the clinical characteristics of 13 patients sheds light on the nature of cases outside of Wuhan, China.

The US Department of Health and Human Services announced that it is expanding an existing collaboration with Regeneron Pharmaceuticals in order to pursue a treatment for the 2019 novel coronavirus.

An article concludes that there has been human-to-human transmission among close contacts since the middle of December 2019.

Gilead Sciences is collaborating with Chinese, US, and global health officials in order to investigate the safety and efficacy of their investigational antiviral compound remdesivir against the novel coronavirus.

The US Food and Drug Administration has authorized the use of a new diagnostic for 2019 novel coronavirus.

Alex Azar has declared a public health emergency in the United States in response to the 2019 novel coronavirus but says the risk to Americans remains low.

As January comes to an end, we’re looking back at important infectious disease news from the past month.

The CDC has also announced the first confirmed non-travel associated case of novel coronavirus in the United States.

The WHO will reconvene on Thursday, January 30, 2020, to discuss whether the novel coronavirus should be designated a public health emergency of international concern.

A new article published in The Lancet features information on epidemiology, laboratory, and radiology elements of the first 41 cases of the novel coronavirus confirmed in Wuhan, China.

The WHO Director-General Tedros Adhanom Ghebreyesus, PhD is not declaring the Wuhan Coronavirus outbreak a Public Health Emergency of International Concern at this time.

The CDC has announced that travelers from Wuhan will undergo entry screening at airports in New York, San Francisco, and Los Angeles.

Infection preventionist Saskia Popescu discusses several rapid developments that have been released in this outbreak.

As of January 5, 2020 there have been 59 confirmed cases associated with the pneumonia outbreak in Wuhan city.

What you should know before you travel this winter season.

A newly identified porcine virus has been found to be able to get into human cells in the laboratory setting.

As healthcare-associated infections continue to be life-threatening, Clorox Healthcare continues to provide bacteria- and virus-killing products that aim to reduce the risk of infection.